Skip to main content

Table 3 Clinical characteristics of breast and ovarian cancer cases included in the study

From: Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)

 

Hereditary breast/ovarian cancer study

Cancer Registry

P-value

High risk BRCA1+

n (%)

High risk BRCA2+

n (%)

High risk BRCA-

n (%)

Low risk

n (%)

Breast cancer

 Laterality

  Right

11 (37.9%)

22 (41.5%)

153 (48.1%)

51 (44%)

2003 (47.4%)

 

  Left

17 (58.6%)

27 (50.9%)

155 (48.7%)

61 (52.6%)

2142 (50.7%)

 

  Bilateral

1 (3.5%)

4 (7.6%)

10 (3.2%)

4 (3.5%)

78 (1.8%)

0.021 (a)

  Total

29

53

318

116

4223

 

(a) BRCA2+ vs Cancer Registry: OR = 4.3; 95% CI = 1.3 to 11.4

 Stage

  Localized

10 (40%)

24 (47.1%)

154 (57.2%)

56 (59.6%)

2396 (57%)

 

  Regional

13 (52%)

24 (47.1%)

105 (39%)

36 (38.3%)

1618 (38.5%)

 

  Advanced

2 (8%)

3 (5.9%)

10 (3.7%)

2 (2.1%)

189 (4.5%)

0.043 (b)

  Total

25

51

269

94

4203

 

(b) BRCA1/2 vs Cancer Registry

 Age at diagnosis in years

  Mean (standard deviation)

44.3 (8.98)

44.12 (10.17)

45.72 (10.34)

50.14 (11.44)

60.79 (15.47)

 

  Number

30

53

327

120

4384

 

  p-value

< 0.001

< 0.001

< 0.001

< 0.001

Reference

 

Ovarian cancer

 Laterality

  Right

1 (11.1%)

0

6 (46.2%)

3 (60%)

100 (37.2%)

 

  Left

1 (11.1%)

2 (66.7%)

3 (23.1%)

2 (40%)

86 (32%)

 

  Bilateral

7 (77.8%)

1 (33.3%)

4 (30.8%)

0

83 (30.9%)

0.007 (c)

  Total

9

3

13

5

269

 

(c) BRCA1+ vs Cancer Registry: OR = 7.8; 95% CI = 1.7 to 55.7

 Stage

  Localized

1 (9.1%)

1 (25%)

6 (25%)

2 (28.6%)

28 (23%)

 

  Advanced

10 (90.9%)

3 (75%)

18 (75%)

5 (71.4%)

94 (77%)

0.43 (d)

  Total

11

4

24

7

122

 

(d) BRCA1/2 vs Cancer Registry

 Age at diagnosis in years

  Mean (standard deviation)

54.12 (12.03)

53.33 (14.68)

53.29 (10.86)

54.55 (13.08)

65.63 (15.43)

 

  Number

13

7

27

8

561

 

  p-value

0.007

0.078

< 0.001

0.057

Reference